China Contract Research Organization (CRO) Industry Report ,2013-2016: Industry Shares, Size, Trend and Analysis to 2016 Report Available at MarketResearchReports.Biz
(PRWEB) May 26, 2014 -- China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share.
As China is full of talents, has advantage of relatively low costs and is rich in disease spectrum, the world’s renowned CRO companies, including Quintiles, Covance, Parexel and Charles River, have entered the Chinese market through sole proprietorship, corporation or acquisition, driving the industry towards standardization to some extent.
Browse Full Report With Toc:
http://www.marketresearchreports.biz/analysis-details/china-contract-research-organization-cro-industry-report2013-2016
At present, there are about 500 companies involved in CRO market in China, but only a few of them are operating at scale and in good shape. WuXi AppTec, ShangPharma Corp, Asymchem and Hangzhou Tigermed Consulting Co., Ltd. Are the leading local CRO companies in China, together holding around 15% of China CRO market.
WuXi AppTec is the largest local CRO player in China, making up about 10% of China CRO market; Hangzhou Tigermed Consulting Co., Ltd. is the only local CRO company listed in China, whose revenue has increased at a rate of above 30% annually over the last three years; Asymchem Inc. takes medical CMO as primary business, with its revenue arriving at RMB 542.8 million in 2013, and has embarked on IPO.
In order to share resources and improve overall competitiveness, some Chinese CRO companies are realizing mutual development by creating alliances, such as Alliance of Biotechnology Outsourcing (or ABO, including 38 companies such as Sino Biological Inc. and Pharmaron). In 2013, the revenue of ABO topped RMB 2 billion, up 11% from a year ago, of which RMB 1 billion came from international services.
To Download Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/206137
Table of Content
1. Overview of Pharmaceutical Outsourcing
1.1 Definition
1.2 Classification
1.3 CRO
2. Overview of China CRO Market
2.1 Status Quo
2.2 Market Size
2.3 Competitive Landscape
2.4 Market Characteristics
3. Development Environment of China CRO Industry
3.1 International Environment
3.1.1 Development History
3.1.2 Development Status Quo
3.1.3 Industry Status Quo
3.2 Industry Environment
3.3 Regional Market
To Read More Reports With TOC: http://www.marketresearchreports.biz/analysis/206137
4. Key Foreign CRO Companies
4.1 Covance
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Development in China
4.2 Parexel
5. Key Chinese CRO Players
5.1 Wuxi AppTec
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Investment
5.1.6 Forecast and Outlook
6. Conclusion and Forecast
6.1 Size of China CRO Market
6.2 Operation Comparison of CRO Companies in China
6.2.1 Revenue
6.2.2 Net Income
6.2.3 Gross Margin
Latest Reports:
Biotechnology Equipment Markets In China
Browse Full Report with Toc:
http://www.marketresearchreports.biz/analysis-details/biotechnology-equipment-markets-in-china
China's demand for biotechnology equipment has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Table of Content
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. BIOTECHNOLOGY EQUIPMENT INDUSTRY ASSESSMENTS
IV. BIOTECHNOLOGY EQUIPMENT SALES VOLUMES AND FORECASTS
V. BIOTECHNOLOGY EQUIPMENT MARKET OUTLOOKS
VI. MARKETING STRATEGIES
To Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/193632
VII. BIOTECHNOLOGY EQUIPMENT PRODUCER DIRECTORY
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. BIOTECHNOLOGY EQUIPMENT INDUSTRY ASSESSMENTS
IV. BIOTECHNOLOGY EQUIPMENT SALES VOLUMES AND FORECASTS
V. BIOTECHNOLOGY EQUIPMENT Y MARKET OUTLOOKS
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. BIOTECHNOLOGY EQUIPMENT INDUSTRY ASSESSMENTS
IV. BIOTECHNOLOGY EQUIPMENT SALES VOLUMES AND FORECASTS
V. BIOTECHNOLOGY EQUIPMENT BY MARKET OUTLOOKS
Global And China Biodegradable Plastics Industry Report, 2013 - 2016
Browse Full Report with Toc:
Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties developed so far, only plastarch material (PSM), polylactic acid (PLA), poly(butylene succinate) (PBS) have realized mass industrial production. In 2013, PSM, PLA and PBS accounted for 87% of the world’s total capacity.
In 2013, demand from Europe and North America, the two main biodegradable plastic markets around the world, for biodegradable plastics accounted for 54% and 28%, respectively. Germany-based BASF, U.S.-based NatureWorks (Thailand’s PTT Chemical paid US$150 million for a 50% stake in NatureWorks in December 2011), Italy’s Novamont as well as the Netherlands-based Purac are the world’s major suppliers of biodegradable plastics, with capacity of 140 kt/a, 140 kt/a, 80 kt/a, 80 kt/a, respectively.
To Download Full Report with Toc:
http://www.marketresearchreports.biz/sample/sample/192499
China as one of the world’s important suppliers of biodegradable plastics accounts for about 20% of global production capacity. In 2009-2013, its biodegradable plastic capacity grew at a compound annual growth rate of over 21%. And, under the stimulus of favorable national policies as well as expanding range of applications, many domestic enterprises have embarked on new construction or expansion of biodegradable plastics.
As a leader in domestic plastics industry, Kingfa Sci & Tech Co., Ltd. mainly produces modified plastics, specialty engineering plastics, completely biodegradable plastics, carbon fiber and composite materials, of which, the 30 kt/a PBS and polybutylene succinate adipate (PBSA) has been put into operation in Zhuhai in 2011, the Phase II 90 kt/a PBSA expansion project will be launched. Meanwhile, Kingfa is also increasing intensity of downstream demand expansion. The company has signed biodegradable plastic mulch demonstrative application agreements with Xinjiang Production and Construction Corps, Guizhou, Shandong and other provinces and cities in early 2014.
About us
MarketResearchReports.biz http://www.marketresearchreports.biz/ is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Gunakesh Parmar, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article